lysergic acid diethylamide has been researched along with ly 341495 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Maeso, J; Holloway, T; Moreno, JL; Rayannavar, V; Sealfon, SC | 1 |
1 other study(ies) available for lysergic acid diethylamide and ly 341495
| Article | Year |
|---|---|
Chronic treatment with LY341495 decreases 5-HT(2A) receptor binding and hallucinogenic effects of LSD in mice.
Topics: Amino Acids; Animals; Drug Antagonism; Early Growth Response Protein 1; Early Growth Response Protein 2; Hallucinogens; Lysergic Acid Diethylamide; Male; Mice; Mice, Knockout; Proto-Oncogene Proteins c-fos; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptors, Metabotropic Glutamate; Somatosensory Cortex; Stereotyped Behavior; Xanthenes | 2013 |